Research reverses reproductive clock in mice
Finding offers hope to women struggling to conceive.
Australian researchers have lifted fertility rates in older female mice with small doses of a metabolic compound that reverses the ageing process in eggs.
A collaboration between the University of Queensland (UQ) and UNSW, with input from Harvard University, US, the study found a non-invasive treatment could maintain or restore the quality and number of eggs and alleviate the biggest barrier to pregnancy for older women.
The researchers found the loss of egg quality through ageing was due to lower levels of a particular molecule in cells critical for generating energy.
“Quality eggs are essential for pregnancy success because they provide virtually all the building blocks required by an embryo,” says UQ’s Hayden Homer.
“We investigated whether the reproductive ageing process could be reversed by an oral dose of a ‘precursor’ compound – used by cells to create the molecule.”
The molecule in question is known as NAD (nicotinamide adenine dinucleotide) and the precursor as NMN (nicotinamide mononucleotide).
Homer says fertility in mice starts to decline from around one year of age due to defects in egg quality similar to changes observed in human eggs from older women.
“We treated the mice with low doses of NMN in their drinking water over four weeks, and we were able to dramatically restore egg quality and increase live births during a breeding trial,” he says.
Poor egg quality had become the single biggest challenge facing human fertility in developed countries.
“IVF cannot improve egg quality, so the only alternative for older women at present is to use eggs donated by younger women,” says Homer.
“Our findings suggest there is an opportunity to restore egg quality and in turn female reproductive function using oral administration of NAD-boosting agents – which would be far less invasive than IVF.
“It is important to stress, however, that although promising, the potential benefits of these agents remains to be tested in clinical trials”.
The study is described in a paper in the journal Cell Reports.